Costly cancer drug to be covered by Medicare

(By – Robert Pear, THE NEW YORK TIMES)

The Obama administration has decided that Medicare will pay for one of the newest, most-expensive cancer medications, which costs about $178,000 for a standard course of treatment. Read more…


Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or